| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
0.0001 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.21 |
0.0004 |
| mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0007 |
| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.0009 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.36 |
0.001 |
| mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.002 |
| mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.003 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |